About Index Trending news
Analyze
Top 50 Pricing
Kineta, Inc

Kineta, Inc

Work at Kineta, Inc? Add yourself to this profile

Kineta, Inc

Kineta is a nationally-recognized biotechnology company developing novel autoimmune, antiviral and chronic pain therapeutics

Elsewhere

Alexa global traffic share

Twitter followers

21 Jul 2016
$1,500,000
Grant
The Wellcome Trust

Kineta Secures NIAID Funding to Expand Testing of Immune Modulators

yahoo
+2
25 May 2016
$760,780
Venture capital (Series Undisclosed)

SEC FORM D/A

sec
29 Jul 2015
$4,000,000
Grant
National Institute of Allergy and Infectious Diseases

Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others

GeekWire